Rayence Co., Ltd. (KOSDAQ:228850)

Market Cap	82.62B
Revenue (ttm)	111.39B
Net Income (ttm)	495.35M
Shares Out	15.74M
EPS (ttm)	31.48
PE Ratio	166.78
Forward PE	9.89
Dividend	100.00 (1.86%)
Ex-Dividend Date	Dec 29, 2025

Volume	11,863
Average Volume	12,689
Open	5,350.00
Previous Close	5,390.00
Day's Range	5,230.00 - 5,350.00
52-Week Range	5,110.00 - 7,570.00
Beta	0.54
RSI	42.23
Earnings Date	Nov 11, 2025

About Rayence

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides rad...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 2011
• Employees: 230
• Stock Exchange: KOSDAQ
• Ticker Symbol: 228850

Financial Performance

In 2024, Rayence's revenue was 125.56 billion, a decrease of -12.18% compared to the previous year's 142.99 billion. Earnings were 7.83 billion, a decrease of -60.05%.